Biology and treatment of ductal carcinoma in situ (Q36731414)

15 August 2017

1 reference

title

Biology and treatment of ductal carcinoma in situ (English)

1 reference

15 August 2017

1 reference

Tracey Irvine

1

1 reference

15 August 2017

Ian S Fentiman

series ordinal

2

1 reference

15 August 2017

publication date

1 February 2007

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

135-145

1 reference

Incidence of and treatment for ductal carcinoma in situ of the breast.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Prospective study of non-infiltrating carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Intraductal breast cancer: review of 183 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Breast carcinoma in situ: risk factors and screening patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Patterns of chromosomal alterations in breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

A prognostic index for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Ductal carcinoma in situ with microinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Balance of cell proliferation and apoptosis in breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Overexpression of cyclooxygenase-2 is associated with breast carcinoma and its poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Prospective study of wide excision alone for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

The management of ductal carcinoma in situ in North America and Europe. Results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Mammographic density and breast cancer after ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Trends in the treatment of ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Patterns and correlates of local therapy for women with ductal carcinoma-in-situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Does mammary ductoscopy have a role in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

Ductal Carcinoma in Situ of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

CHANGES IN THE MANAGEMENT OF DUCTAL CARCINOMA IN SITU BEFORE THE RELEASE OF CLINICAL PRACTICE RECOMMENDATIONS IN AUSTRALIA: THE CASE IN VICTORIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.135

21 January 2018

Identifiers

DOI

10.1586/14737140.7.2.135

1 reference

15 August 2017

1 reference